FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Claire Dearden

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Procedures

Phenomena

Recurrence

Genes & Molecular Sequences

Single Nucleotide Polymorphism

Co-author Network

Publications

TOP 3
M C Di Bernardo; M J S Dyer; S Harris; P Broderick; Daniel Catovsky; Claire Dearden; Estella Matutes; R S Houlston
Risk of developing chronic lymphocytic leukemia is influenced by HLA-A class I variation.
Monica Else; Ana Marín-Niebla; Eduardo Ríos; Paul Batty; Daniel Catovsky; Fátima de la Cruz; Claire Dearden; Estella Matutes
Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma.
Sarah L Hockley; Alison Morilla; Andrew Wotherspoon; Daniel Catovsky; Claire Dearden; Monica Else; David Gonzalez; Estella Matutes
The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Claire Dearden (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: M C Di Bernardo; M J S Dyer; S Harris; P Broderick; Daniel Catovsky; Claire Dearden; Estella Matutes; R S Houlston
Risk of developing chronic lymphocytic leukemia is influenced by HLA-A class I variation.
Leukemia 2013;27(1):255-8.
2012: Monica Else; Ana Marín-Niebla; Eduardo Ríos; Paul Batty; Daniel Catovsky; Fátima de la Cruz; Claire Dearden; Estella Matutes
Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma.
British journal of haematology 2012;159(3):322-8.
2012: Sarah L Hockley; Alison Morilla; Andrew Wotherspoon; Daniel Catovsky; Claire Dearden; Monica Else; David Gonzalez; Estella Matutes
The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma.
British journal of haematology 2012;158(3):347-54.
2011: Claire Dearden; Monica Else; Effie Grand; Mike Hamblin; Saman Hewamana; Amit Khot; Estella Matutes; Ashok Roy; Daniel Catovsky
Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route.
Blood 2011;118(22):5799-802.
2011: S L Hockley; P E Leone; Daniel Catovsky; Claire Dearden; Monica Else; D Gonzalez; Gareth J Morgan; Alison Morilla; Brian A Walker; Andrew Wotherspoon; Estella Matutes
High-resolution genomic profiling in hairy cell leukemia-variant compared with typical hairy cell leukemia.
Leukemia 2011;25(7):1189-92.
2011: Saman Hewamana; Claire Dearden
Treatment options for high-risk chronic lymphocytic leukaemia.
Therapeutic advances in hematology 2011;2(3):147-59.
2011: Claire Dearden; Monica Else; Daniel Catovsky
Long-term results for pentostatin and cladribine treatment of hairy cell leukemia.
Leukemia & lymphoma 2011;52 Suppl 2():21-4.
2011: Monica Else; Claire Dearden; Estella Matutes; Francesco Forconi; Francesco Lauria; Humayun Ahmad; Susan Kelly; Anandika Liyanage; Vijitha Ratnayake; Jagadeesan Shankari; Ioana Whalley; Daniel Catovsky
Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence.
Leukemia & lymphoma 2011;52 Suppl 2():75-8.
2011: Claire Dearden
Large granular lymphocytic leukaemia pathogenesis and management.
British journal of haematology 2011;152(3):273-83.
2010: William G Wierda; Nicholas Chiorazzi; Claire Dearden; Jennifer R Brown; Emili Montserrat; Elizabeth Shpall; Stephan Stilgenbauer; Sabeeha Muneer; Michael Grever
Chronic lymphocytic leukemia: new concepts for future therapy.
Clinical lymphoma, myeloma & leukemia 2010;10(5):369-78.
2010: Biju Krishnan; Monica Else; Geir E Tjonnfjord; Bruno Cazin; Dennis Carney; John Carter; Nicolas Ketterer; Daniel Catovsky; Mark Ethell; Estella Matutes; Claire Dearden
Stem cell transplantation after alemtuzumab in T-cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study.
British journal of haematology 2010;149(6):907-10.
2010: Dalemari Crowther-Swanepoel; Peter Broderick; Yussanne Ma; Lindsay Robertson; Alan Pittman; Amy Price; Philip Twiss; Jayaram Vijayakrishnan; Mobshra Qureshi; Martin J S Dyer; Estella Matutes; Claire Dearden; Daniel Catovsky; richard Houlston
Fine-scale mapping of the 6p25.3 chronic lymphocytic leukaemia susceptibility locus.
Human molecular genetics 2010;19(9):1840-5.
2010: Parameswaran Anoop; Girish Ravindranathan; Nnenna Osuji; Claire Dearden; Andy Wotherspoon; Barbara J Bain; Estella Matutes
Epstein-Barr virus negative large B-cell lymphoma during long term immunomodulatory therapy for T-cell large granular lymphocytic leukaemia.
British journal of haematology 2010;148(2):337-9.
2009: Dalemari Crowther-Swanepoel; Mobshra Qureshi; Martin J S Dyer; Estella Matutes; Claire Dearden; Daniel Catovsky; richard Houlston
Genetic variation in CXCR4 and risk of chronic lymphocytic leukemia.
Blood 2009;114(23):4843-6.
2009: Monica Else; Claire Dearden; Estella Matutes; Juan Garcia-Talavera; Ama Z S Rohatiner; Steve A N Johnson; Nigel T J O'Connor; Andy Haynes; Nnenna Osuji; Francesco Forconi; Francesco Lauria; Daniel Catovsky
Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis.
British journal of haematology 2009;145(6):733-40.
2009: Claire Dearden
T-cell prolymphocytic leukemia.
Clinical lymphoma & myeloma 2009;9 Suppl 3():S239-43.
2007: Monica Else; Nnenna Osuji; Francesco Forconi; Claire Dearden; Ilaria Del Giudice; Estella Matutes; Andrew Wotherspoon; Francesco Lauria; Daniel Catovsky
The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia.
Cancer 2007;110(10):2240-7.
2007: Daniel Catovsky; S Richards; Estella Matutes; David Oscier; Martin J S Dyer; R F Bezares; Andrew R Pettitt; Terry J Hamblin; D W Milligan; J A Child; malcolm Hamilton; Claire Dearden; A G Smith; A G Bosanquet; Zadie Davis; Vasantha Brito-Babapulle; M Else; R Wade; Peter Hillmen
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial.
Lancet 2007;370(9583):230-9.
2006: Claire Dearden; Monica Else
Hairy cell leukemia.
Current oncology reports 2006;8(5):337-42.
2005: Monica Else; Rosa Ruchlemer; Nnenna Osuji; Ilaria Del Giudice; Estella Matutes; Anthony Woodman; Andrew Wotherspoon; John Swansbury; Claire Dearden; Daniel Catovsky
Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years.
Cancer 2005;104(11):2442-8.
2005: Stefan Faderl; Steven Coutré; John C Byrd; Claire Dearden; A Denes; Martin J S Dyer; S A Gregory; J G Gribben; Peter Hillmen; Michael Keating; S Rosen; P Venugopal; Kanti Rai
The evolving role of alemtuzumab in management of patients with CLL.
Leukemia 2005;19(12):2147-52.
2005: Farhad Ravandi; Andrew Lamb; Dan Jones; Claire Dearden; Michael Keating; Susan O'Brien
Mature T-cell leukemias.
Cancer 2005;104(9):1808-18.
2005: Nnenna Osuji; Ilaria Del Giudice; Estella Matutes; Andrew C Wotherspoon; Claire Dearden; Daniel Catovsky
The efficacy of alemtuzumab for refractory chronic lymphocytic leukemia in relation to cytogenetic abnormalities of p53.
Haematologica 2005;90(10):1435-6.
2005: Jeanette Lundin; Ben Kennedy; Claire Dearden; Martin J S Dyer; Anders Osterborg
No cardiac toxicity associated with alemtuzumab therapy for mycosis fungoides/Sézary syndrome.
Blood 2005;105(10):4148-9.
2005: Nnenna Osuji; Estella Matutes; Claire Dearden; Daniel Catovsky
Pregnancy improves neutropenia in T-cell large granular lymphocyte leukaemia.
British journal of haematology 2005;128(5):645-8.
2004: Daniel Catovsky; Estella Matutes; Claire Dearden; Nnenna Osuji; Vasantha Brito-Babapulle
The WHO classification of mature T-cell leukemias.
Blood 2004;104(9):2989-90; author reply 2990.
2004: Michael Keating; Steven Coutré; Kanti Rai; Anders Osterborg; Stefan Faderl; Ben Kennedy; Tom Kipps; Gerald P Bodey; John C Byrd; Steven Rosen; Claire Dearden; Martin J S Dyer; Peter Hillmen
Management guidelines for use of alemtuzumab in B-cell chronic lymphocytic leukemia.
Clinical lymphoma 2004;4(4):220-7.
2001: Claire Dearden; Estella Matutes; B Cazin; Geir Tjønnfjord; A Parreira; B Nomdedeu; P Leoni; F J Clark; D Radia; S M Rassam; T Roques; N Ketterer; Vasantha Brito-Babapulle; Martin J S Dyer; Daniel Catovsky
High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H.
Blood 2001;98(6):1721-6.